982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)

類似資料

• 982 Immune mediated mechanisms of PARPi resistance in BRCA1-associated triple negative breast cancer (TNBC)
  著者:: Geoffrey I Shapiro, 等
  出版事項: (2023-11-01)
• STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancer
  著者:: Constantia Pantelidou, 等
  出版事項: (2022-09-01)
• Role of PARP in TNBC: Mechanism of Inhibition, Clinical Applications, and Resistance
  著者:: Desh Deepak Singh, 等
  出版事項: (2021-10-01)
• PARP Inhibitors in the Management of BRCA-Positive Prostate Cancer: An Overview
  著者:: Islam Kourampi, 等
  出版事項: (2023-01-01)
• Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies
  著者:: Marilyne Labrie, 等
  出版事項: (2021-10-01)